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Background: Multiple tasking is an integral part of daily mobility. Patients with Parkinson’s disease have dual
tasking difficulties due to their combined motor and cognitive deficits. Two contrasting physiotherapy interventions
have been proposed to alleviate dual tasking difficulties: either to discourage simultaneous execution of dual tasks
(consecutive training); or to practice their concurrent use (integrated training). It is currently unclear which of these
training methods should be adopted to achieve safe and consolidated dual task performance in daily life. Therefore,
the proposed randomized controlled trial will compare the effects of integrated versus consecutive training of dual
tasking (tested by combining walking with cognitive exercises).
Methods and design: Hundred and twenty patients with Parkinson’s disease will be recruited to participate in this
multi-centered, single blind, randomized controlled trial. Patients in Hoehn & Yahr stage II-III, with or without freezing
of gait, and who report dual task difficulties will be included. All patients will undergo a six-week control period without
intervention after which they will be randomized to integrated or consecutive task practice. Training will consist of
standardized walking and cognitive exercises delivered at home four times a week during six weeks. Treatment is
guided by a physiotherapist twice a week and consists of two sessions of self-practice using an MP3 player. Blinded
testers will assess patients before and after the control period, after the intervention period and after a 12-week
follow-up period. The primary outcome measure is dual task gait velocity, i.e. walking combined with a novel
untrained cognitive task to evaluate the consolidation of learning. Secondary outcomes include several single and
dual task gait and cognitive measures, functional outcomes and a quality of life scale. Falling will be recorded as a
possible adverse event using a weekly phone call for the entire study period.
Discussion: This randomized study will evaluate the effectiveness and safety of integrated versus consecutive task
training in patients with Parkinson’s disease. The study will also highlight whether dual task gait training leads to
robust motor learning effects, and whether these can be retained and carried-over to untrained dual tasks and
functional mobility.
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Parkinson’s disease (PD) is a common, multisystem neuro-
degenerative disease which is characterized by motor and
non-motor symptoms [1]. The motor symptoms of PD are
manifold but include gait and balance disorders, which
have a significant impact on functional mobility and qual-
ity of life [2]. Depending on the disease stage, up to 79.2
percent of patients (advanced stage) may report to have
freezing of gait (FOG) [3], which is a disabling gait
disorder characterized by episodes of lack of forward
progression despite the intention to walk [4]. Approxi-
mately 60% of patients fall each year and about two thirds
fall recurrently [5-7].
Dual tasking is the simultaneous performance of two
attention-demanding tasks with different goals, whereby
one task can be denoted as the primary and the other as
the secondary task [8]. Factors that affect dual task
performance are the environment in which the task
takes place, the nature of the secondary task, the age
and disease-specific factors of each individual [9]. Gait
has been found to deteriorate during dual task (DT)
performance in PD [10-14], resulting in a decrease of gait
velocity, cadence and step length [9,13-18], an increase
in gait variability [9,13,17,19] and an increase in double
support time [14,20]. Also, falling and FOG are more
commonly provoked in DT conditions [11,21,22].
Mild cognitive impairment is thought to occur in 20-
57% of PD patients, even as early as 3–5 years after the
diagnosis [23,24]. Several studies have indicated that
executive dysfunction is a robust determinant of DT
interference at least in mid but not in early stage PD
[13,17,25,26]. Executive function refers to a set of abil-
ities which flexibly guide behavior towards goals and
includes switching between cognitive sets or tasks, ap-
propriately inhibiting and generating responses and
updating working memory contents [27,28]. Wild et al.
[13] showed that cognitive performance in PD worsened
during DT walking and that this was correlated to global
cognitive condition.
Motor learning is highly dependent on cognitive status
in PD [29,30]. Patients with freezing of gait (FOG) showed
greater executive deficits than their non-freezing counter-
parts [31-33] and were also found to learn a serial reaction
time task less well [34]. This raises the question as to the
extent of the cognitive challenge which is appropriate for
achieving robust learning in PD.
Evidence for the efficacy of physiotherapy is growing
in PD [35,36]. Various modes of gait training were found
effective in improving gait velocity [37,38]. Although more
controlled studies remain needed, cognitive training shows
promising benefits in several cognitive domains including
executive function in PD [39]. Despite the fact that
evidence-based physiotherapy guidelines discourage the
use of dual task exercise [40], a number of open labelstudies [38,41-46] support the feasibility and efficacy of
DT training in PD [45,46]. Hence, a phase III randomized
study is currently being undertaken in which the effect of
single and dual task gait training is compared in a wide
variety of PD patients [47].
The current trial proposes to test the efficacy of two
strategies for DT training. The first strategy entails
consecutive task training (CTT), whereby each task
will be trained separately. We expect that as a result of
this type of training, performance of each task may become
more automatic and thus free residual brain capacity for
subsequent simultaneous task performance. The second
strategy proposes integrated dual task practice (IDT). We
expect that this training mode may increase the efficiency
of shared neural resources [48] and as such improve DT
performance. IDT may have additional benefits over CTT
as this training mode may also improve the efficiency of
specific brain areas involved in task integration [49,50],
enhance executive function and ease the transfer of learn-
ing to daily DT situations. Moreover, an advantage of IDT
is that dual tasking can realistically never be avoided
entirely, so it might be wise to prepare patients for
such inevitable dual task events that commonly occur
in daily life. Interestingly, in balance-impaired older
adults, IDT and CTT led to largely similar performance
increases with the exception of better retention in IDT
[51,52]. These findings call for replication, and importantly,
it is currently unknown to what extent these results apply
to PD patients.
Therefore, the primary aim of this study is to compare
the effectiveness of consecutive versus integrated training
(tested by combining walking with cognitive exercises)
on DT gait performance in PD. We hypothesize that IDT
practice will resort in better dual task outcomes and better
consolidated learning results, particularly in patients with-
out cognitive impairment. As secondary questions we will
examine which dual task training mode is most beneficial
in terms of fall risk reduction and leads to the best dual
task gains in freezers versus non-freezers. Here, we de-
scribe the design of this training study, also referred to
as the DUALITY trial.
Methods/design
Study design and setting
The study has a parallel group design and involves a
dual-centered, single blind, randomized controlled trial
with a 12 week follow-up period. The study will include
120 patients with PD of Hoehn & Yahr stage II to III
[53]. Individuals with PD will be randomly allocated to
two arms: (a) six weeks of integrated dual task training
(IDT); or (b) six weeks of consecutive task training (CTT).
Both interventions will be delivered at the patient’s home
with the same frequency and intensity: 12 supervised
sessions by a physiotherapist and 12 unsupervised training
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undergo a six week control period without training to
ascertain the effect of repeated measures (Figure 1). All
other interventions (medication, allied health care) will
be kept as stable as possible. Any changes in treatment
or medication will be monitored. The trial will be con-
ducted in two countries. Sixty patients will be recruited
at the Radboud University Medical Center (RUMC) in
the Netherlands and sixty patients will be recruited at
the University Hospitals in Belgium.
Participants
Inclusion criteria for recruitment are: (a) diagnosis of PD
according to the UK Brain Bank criteria [54]; (b) Hoehn
and Yahr stage II-III in the subjective best ON-phase
of the medication cycle [53]; (c) able to walk 10 minutes
continuously; (d) presence of dual task interference as
established by a structured checklist (see Table 1); (e) aRecruitment o
60 patients at RUM
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Figure 1 Design of the Duality study. PD: Parkinson’s disease. RUMC: Rad
Leuven. DT: dual task. PT: physiotherapist.score ≥ 24 on the Mini Mental State Examination (MMSE)
[55]; (f) stable medication over the past 3 months; (g) no
hearing and visual problems that interfere with testing or
training; and (h) stable Deep Brain Stimulator (DBS) set-
tings over the past year. Exclusion criteria are: (a) unstable
medical conditions including acute orthopedic conditions
affecting gait; and (b) ongoing dual task training or other
interfering physical therapy. Patients who received dual
task training in the past are allowed to participate if at
the moment of inclusion they report to have dual task
problems based on a structured checklist (Table 1). Re-
cruitment of patients will be conducted via the databases
of the Movement Disorder clinic at University Hospitals
Leuven and RUMC and affiliated medical centers. All in-
terested participants will be screened by a physiotherapist
during a first home visit in which informed consent
will be obtained and inclusion criteria applied. Full
ethical approval has been granted for the study in thef 120 PD patients   
C – 60 patients at KUL 
 screening
 evaluation 1
nitive function, quality of life
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Table 1 Dual task screening list to determine dual task
problems
Do you experience difficulties
with the combination of …
Yes No Not applicable
Walking and talking
Walking and phoning
Walking and carrying a bag
Walking and carrying a plate filled with food
Walking and carrying a filled glass
Walking and avoiding obstacles
Walking and getting something out of your
pockets (tissue, money, mobile phone)
Walking outside and paying attention
to traffic
Walking and remembering things (phone
number, address)
Walking and thinking about something else
Walking and looking for items while shopping
Walking and closing the zipper of your jacket
Walking and finding your way in airport or
train station
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ID/number NL39530.091.12 and in Belgium (CME KU
Leuven) B322201213165/S53419.
Sample size
Primary outcome is DT gait velocity. Single task gait
velocity changes of around 0.05 m/s have been found
clinically meaningful [38] but no such data presently
exist for dual task gait velocity. Sample size power calcula-
tion [56] was based on data from the RESCUE trial in
which in a similar study population had a mean dual task
gait speed of 0.77 m/s (SD = 0.21) [38,57]. Power was set
at 80% and based on two-sided 95% confidence intervals.
We assumed that there would be a difference of 15% be-
tween both arms in favor of IDT based on previous study
[51]. In analogy to the RESCUE study, in which a home-
based intervention was delivered, a drop-out rate of 5%
was envisaged. Assuming a stable control period, we cal-
culated our sample size to include a total of 108 subjects
(54 per center). Incorporating a loss to follow-up, we will
aim to recruit 60 patients (total of 120 subjects) per group
over a period of two years.
Randomization and blinding
Subjects will be randomly assigned per center to the
earlier described integrated dual task (IDT) or consecutive
task training (CTT). A computerized block randomization
procedure will be implemented by an independent statisti-
cian using a block size of four subjects. Group allocation
will be performed by an independent person, who will
notify the treating physiotherapist by email to ensureconcealed allocation. Randomization will be stratified
by subgroup with or without FOG and by stage of the
disease (Hoehn & Yahr stage II and III). To avoid bias,
patients are assessed by blinded testers. In addition,
participants will be explicitly instructed not to reveal
any details about their training regime during testing
to prevent unblinding. Both therapists and patients will
be explained that both arms of the study are likely to be
effective in improving dual task performance to control
for expectancy effects, in line with the above outlined ra-
tionale for each training approach.
Intervention
Both interventions are delivered by trained physiothera-
pists, twice a week at the patient’s home. These sessions
entail 30 minutes of supervised gait and cognitive exer-
cises and 10 minutes of functional practice. Unsupervised
exercises will be conducted twice a week for 30 minutes
and include gait and mental practice using an MP3 player.
MP3-player delivery of cognitive training was found feas-
ible in an earlier pilot DT study [45]. User-friendly devices
with a large display and buttons (DIFRNCE MP1850) will
be used (Figure 2a). Therapists will assess whether the
home exercise is perceived as safe and without risk of fall-
ing or needs to be performed together with a carer.
In order to contrast CTT and IDT training precisely and
ensure that both training arms offered sufficient challenge
for a variety of patients, a standardized program of cogni-
tive training based on structured progression levels was
developed by an expert team of four physiotherapists with
the input of 1 psychologist. Hence, the programs for CTT
and IDT consist of three identical components: (1) gait
practice; (2) auditory cognitive exercise; and (3) functional
training suitable to be delivered at home (Table 2). The
program was piloted on several patients at home in the
first six months of trial preparation.
Table 2 illustrates the components of training in both
study arms. Gait practice involves specific gait exercises
aimed to improve gait quality at home. Progression is
introduced once patients can perform the exercise fluently
(CTT) or without noticeable DT interference (IDT). Cog-
nitive exercises (Table 2) are offered in five categories
demonstrated to cause gait interference in older people
[58]: (1) verbal fluency; (2) discrimination and decision
making tasks; (3) working memory tasks; (4) mental track-
ing tasks; and (5) reaction time tasks. The cognitive exer-
cises and levels of progression are audiotaped, allowing
segments to be played on the therapists’ laptops or on the
MP3 players for self-practice. Subjects will be instructed
to respond to the tasks with spoken word sequences. Ver-
bal responses are monitored and scored by the therapist,
who provides feedback on performance after each bout
of practice. Flawless performance at the starting level
(CTT) or no noticeable interference during DT (IDT)
(d)(c)
(a) (b)
Figure 2 Equipment used during training and testing. (a) MP3-player (DIFRNCE MP1850); (b) GaitRite Electronic Walkway System; (c) wireless
headset system (Beyerdynamic; transmitter: t-bone DS16T and receiver: t-bone IEM100R); (d) large buttoned mobile phone (EmporiaTalkPremium).
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Functional tasks, relevant for each patient, are chosen
for the functional part of the training program to ensure
generalization of practice (Table 2).
Table 2 also shows that in the CTTarm of the study, each
session will consist of 15 minutes of gait practice, 15 mi-
nutes of cognitive practice and 10 minutes of functional
task training. Gait practice is focused on improving gait
quality. Cognitive training is performed while the patient is
sitting on a chair. CTT functional training will emphasize
safety, avoiding dual tasking and carrying out task compo-
nents separately as much as possible. Table 2 also shows
that in contrast IDT is based on performing motor-
cognitive tasks concurrently for 30 minutes right from the
first session. Gait practice is performed while at the same
time verbally responding to the cognitive exercises. Giventhe likely cognitive deterioration in PD [29,30], a fixed pri-
ority of dividing attention on both tasks will be imple-
mented in the beginning of the training, aimed to improve
better and safe walking. If possible a variable locus of at-
tention [51,52] is adopted as the patient progresses. Dur-
ing functional task practice, dual tasking will be positively
encouraged to ensure transfer of learning to daily life.
Rigorous measures of standardization of the interven-
tions are implemented between the two centers by having
a cross-center training week of therapists at the onset of
the trial and by regular follow-up meetings.
Testing and outcome measures
Table 3 gives an overview of the outcome measures which
will be tested at various time points. The primary outcome
measure is DT gait velocity while performing an untrained
Table 2 The duality training program
Intensity
6 weeks 2x/week 40 min Therapy session with physiotherapist
2x/week 30 min Therapy session without physiotherapist
Integrated training group Consecutive training group
- Gait training while doing cognitive exercises - Cognitive training while sitting
- Functional training of dual tasks in ADL - Gait training without extra cognitive load
- Consecutive functional training avoiding dual tasks
Contents of components in both training arms
Exercises Progression
Gait training Depending on clinical need walking while: Increase speed
Focussing on big steps Increase amplitude
Focussing on heel strike Increase or decrease frequency
Focussing on arm swing Introduce speed variations
Focussing on upright posture
Walking while raising knees Decrease exercise execution time
Tandem gait Increase coordination demands
Turning Increase environmental demands: surfaces, narrow
spaces, doorways, outdoors
Transitions: sit-to-stand, start-stop
Stepping in multi-directions
Cognitive training Verbal fluency tasks
e.g. Name cities and countries starting with A,B,C More difficult categories
Discrimination and decision making tasks
e.g. Say yes when you hear “strawberry” but say nothing
when you hear another sort of fruit
Decrease response time, responding to two or three
different words
Working memory tasks
e.g. Digit span backwards, Word memory task Increase the length of series, related vs. unrelated words
Mental tracking tasks
e.g. Count how many times you hear the word “cat” in
this story about cats.
Count two or three words in a story
Counting: summing and subtracting Increase the complexity of the counting task
Reaction time tasks
e.g. React as fast as you can on a certain word or sound Decrease time between two reactions, react to two
or three words or sounds
Cognitive exercise is delivered by the therapist using
a laptop.
During self-administered practice, cognitive exercise is
played via an MP3 player
Functional training Integrated training group
Walking while having a conversation
Describing route while walking
Taking wallet, handkerchief, … out pocket while walking
Closing buttons and zipper while walking
Carrying tray, cup, plate
Carrying groceries
Moving kitchenware from sink to cupboard
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Table 2 The duality training program (Continued)
Integrated AND consecutive training group
Laying the table
Picking object from the ground
Maneuvering in bathroom
Getting mail out the mailbox
Self-reported functional difficulties
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following descriptive, disease and cognitive characteristics
assessed at baseline: Dual Task screening questionnaire
(Table 1); MMSE [55]; Montreal Cognitive Assessment
(MoCA) [59,60]; Frontal Assessment Battery (FAB) [61];
Unified Parkinson’s Disease Rating Scale part I, II and IV;
and retrospective fall frequency (past year). Following ques-
tionnaires are assessed at all four time points: the Unified
Parkinson’s Disease Rating Scale part III (MDS UPDRS-III)
[62]; the new Freezing of Gait Questionnaire (new FOGQ)
[63]; the Activities specific Balance Confidence Scale(ABC-
scale) [64]; the Scales for Outcomes of Parkinson’s disease-
Cognition (ScopaCog) [65]; the Alternating Names Test
(ANT)/Alternating Intake Test (AIT) [66] and the Parkin-
son’s disease Questionnaire for quality of life (PDQ-39) [67].
After the 12 weeks follow-up, a qualitative interview
will be conducted probing patients’ perceptions about
the intervention and how it affected their ADL-
performance. All assessments will be performed in the
ON-phase at a standardized moment after medication
intake. Standardization of testing procedures between
the two centers is applied by regular meetings and
shared testing sessions. Any adverse effects will be re-
corded and the weekly number of falls will be determined.
The primary and secondary gait outcomes will be mea-
sured with the same GAITRite Walkway System embedded
in the gait laboratories of both centers [68]. The order
of the GAITRite testing procedures and the clinical test
battery will be conducted randomly but will be kept
constant in each patient. The GAITRite mat, placed in a
quiet laboratory space, uses pressure sensors to detect
footfalls during walking (see Figure 2b). The GAITRite has
been found a reliable system for measuring spatiotemporal
gait parameters over time [68]. Gait outcomes will be
measured with and without secondary tasks at comfort-
able walking speed. An average of two trials per condition
will be used for statistical analysis.
Performance on the secondary tasks will be assessed
during walking as well as in sitting position. The order of
single and dual task assessments is determined randomly
and will remain the same in each test session for an individ-
ual patient. In the DT conditions, a verbal signal is given
to the patient to start walking and at the same time the sec-
ondary task is started to synchronize the measurements.Three secondary tasks are used to assess dual task
performance: (a) an auditory Stroop task [69,70]; (b) a
Backwards Digit Span task [71,72]; and (c) an especially
designed functional mobile phone task (MPT). The audi-
tory Stroop task is an untrained dual task and represents
the primary outcome. During this task, the patient will
verbally respond to congruent and incongruent high and
low tones. The patient hears three different trials consist-
ing of four stimuli. Stimuli are presented with a variable
interval (1.5 – 2 seconds) to control for cueing effects.
The difficulty level is the same for all participants. The
Stroop task assesses set shifting ability and inhibition
of incongruent responses. During the Backwards Digit
Span task, the patient will have to repeat an array of
numbers in reverse, the length of which will be adapted
to the level of the patient and is determined at baseline.
The Backwards Digit Span is a trained task and loads
working memory, as part of executive function.
Verbal responses to both the Backwards Digit Span
task and the Stroop task will be recorded via a wireless
headset system (Beyerdynamic; transmitter: t-bone
DS16T and receiver: t-bone IEM100R) (Figure 2c). Ver-
bal responses are recorded and saved in the same chan-
nel as the sound fragments, which guarantees optimal
synchronization, and measurement of the number of
correct responses, reaction (Digit Span task and Stroop
task) and response times (Digit Span task). Figure 3
indicates how reaction time is defined for the Stroop and
Digit Span task. Response time is the total duration of
verbalizing a backward sequence of the Digit Span task.
Analysis of reaction and response times will be performed
using Audacity 1.3 Beta program and Matlab (R2011b).
The custom-made mobile phone task is a combined
motor and cognitive task, in which the patients will have to
type the test date (8 numbers) into a large-buttoned mobile
phone (Emporia Talk Premium; Austria) (see Figure 2d).
The number of errors and the time it takes to complete
this task will be measured. The task is an untrained DT
and tests recall and working memory as well as fine
motor skills.
Falls monitoring
For the entire study period of 24 weeks, the patient will
receive a weekly phone call to ask about any fall events in
Table 3 Primary, secondary and tertiary outcome measures
Outcome measures Baseline 1 Baseline 2 Post-intervention 12 week follow-up
Primary outcome measure
DT gait performance Gait velocity Stroop x x x x
Secondary outcome measures
DT gait performance Cadence, Stride length Stroop x x x x
Gait variability Stroop x x x x
Gait velocity, Cadence, Stride length Digit x x x x
Gait variability Digit x x x x
Gait velocity, Cadence, Stride length Mobile x x x x
Phone
Gait variability Mobile Phone x x x x
ST gait performance Gait velocity x x x x
Cadence x x x x
Stride length x x x x
Gait variability measures x x x x
DT cognitive tasks Reaction time digit x x x x
Response time digit x x x x
Errors digit x x x x
Reaction time Stroop x x x x
Errors Stroop x x x x
Errors Mobile phone x x x x
ST cognitive tasks Reaction time digit x x x x
Response time digit x x x x
Errors digit x x x x
Reaction time Stroop x x x x
Errors Stroop x x x x
Errors Mobile phone x x x x
Tertiary outcome measures
Adverse effects Number of falls Weekly follow-up
Motor function MDS-UPDRS III x x x x
New FOGQ x x x x
ABC x x x x
Cognitive function Scopa-Cog x x x x
Alternating fluency (ANT/AIT) x x x x
FAB x - - -
Descriptors Disease duration x - - -
Medication dose x x x x
Hoehn and Yahr stage x - - -
MMSE x - - -
MoCA x - - -
Quality of life PDQ-39 x x x x
Patient experience Focus interview - - - x
DT: Dual task. ST: Single task. MDS-UPDRS part III: Unified Parkinson’s Disease Rating Scale – motor part. H-Y: Hoehn and Yahr stage. New FOGQ: new Freezing of
Gait Questionnaire. ABC: Activities specific Balance Confidence scale. Scopa-Cog: Scales for Outcomes in Parkinson’s disease – cognitive. ANT: Alternating Names
Test. AIT: Alternating Intakes test. MMSE: Mini Mental State Examination. MoCA: Montreal Cognitive Assessment. FAB: Frontal Assessment Battery. PDQ-39:
Parkinson’s Disease Quality of Life Questionnaire.
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a)
b)
Figure 3 Visual presentation of reaction and response times in
Matlab R2011b. (a) Visual presentation of Backwards Digit Span
task – green = stimulus that is heard by the patient, blue = answer of
the patient; (b) Visual presentation of Stroop task. Since four stimuli
per fragment are given, four reaction times per fragment can be
calculated – green = stimulus that is heard by the patient, blue = answer
of the patient.
Table 4 Weekly follow-up of falling
In case of a fall:
Description of fall When did you fall?
At what time of the day?
Can you describe what happened at the
moment you fell?
What were you doing?
What was the cause of the fall?
Where did you fall (inside or outside)?
Medication When was the last time before the fall that
you took medication?
Was this medication still working (on or off)?
Freezing Did freezing occur at the time of the fall?
Dual tasking Were your hands free at the time of the fall?
Were you talking to someone at the time
of the fall?
Adverse aspects related
to fall
Did you have any injury related to the fall?
Are you more afraid of falling?
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about the consequences and specific circumstances in
which the fall took place (Table 4). Individual fall records
will be communicated to the therapist, to enable adapta-
tion of treatment. If a worrying trend of an increased fall
risk would occur as a result of the treatment, therapists
are expected to adapt their treatment accordingly and re-
port this to the safety board of the trial. In addition, thera-
pists will record any falls that may occur during the
intervention. If safety adaptations imply a reduction of theintensity of treatment or in essence will require a change
from an integrated to a consecutive training, patients will
be considered to become a dropout and are included for
the intention to treat analysis. The review board of the trial
will have a six-monthly meeting in which the global fall
rates will be monitored and discussed. A-priori fall rate in-
creases as cutoffs for trial cessation will not be determined
as falling can be very variable in PD and fluctuate according
to medication status.Data analysis/statistics
A statistical analysis plan will be developed prior to
unblinding and analysis. The primary data analysis will be
performed according to an intention to treat principle.
The primary endpoint, the DT walking performance at
test session 1, 2, 3 and 4 will be evaluated using a linear
mixed model. Tests will be two-sided with α 0.05. The
fixed factors will be treatment (IDT vs. CTT), test session
(1, 2, 3 and 4) and the interaction between test session
and treatment group. Subject will be a random factor. The
treatment difference will then be estimated by the appro-
priate contrast for the difference between the mean scores
at test session 1, 2, 3 and 4. Secondary endpoints will be
analyzed in a similar way. As a secondary question we will
also model the three-way interaction between subgroup,
i.e. those with and without freezing of gait (defined as a
score of 1 on the New FOGQ), treatment group and
time. Fall frequency data will be analyzed using a negative
binomial model depending on the distribution of the data.
The influence of center, disease severity (Hoehn and
Yahr scores) and cognition will be explored by including
the interaction terms between treatment and each of these
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intervals will be determined. Sensitivity analyses will
be carried out to evaluate the impact of missing values
on the outcome.
In addition descriptive statistics will be presented by
means and standard deviations, as appropriate. When
data are skewed, medians and quartiles will be calculated
and for categorical data, frequencies and percentages will
be presented.
Data will be analyzed using the data analysis software
package IBM SPSS Statistics (version 19).
Discussion
Acknowledging that dual tasking forms an integral part
of daily functioning, the DUALITY study proposed here
aims to investigate the efficacy and safety of a rehabili-
tation intervention to improve dual tasking in PD pa-
tients. We will establish robust evidence on which training
modality, i.e. integrated or consecutive training, leads to
the best training results and how this compares with a
control period without intervention. Given the reduced
capacity for consolidation of motor learning in PD [49,73]
and the presence of executive deficits [28], it will be
established whether dual task learning effects transfer to
improvements in daily life and are sustained for 12 weeks
without training.
A paucity of dual task studies have been performed in
PD patients, most of which with poor methodological
designs. This pilot work has shown short-term positive
effects on gait performance [42-45], although there was
considerable variation in the population, training period
and tasks (motor, cognitive) that were studied. This is the
first power-based and randomized trial that compares two
interventions in an early to mid-stage PD population that
are both aimed at improving dual task performance but
with contrasting treatment strategies. In analogy with a
DT training study in balance-impaired older people
[51,52], we expect that both groups will show some im-
provement on DT outcomes However, as integrated
DT training is more cognitively challenging we hypothesize
that this will result in a better consolidation and reten-
tion of the training effects in line with motor learning
theory [74]. In addition, we expect that integrated train-
ing will resort in better DT outcomes as the exact prac-
tice conditions mimics real life tasks more closely and
this is important for transfer of learning [74]. In this
study, the evaluation of motor performance will be supple-
mented by assessment of cognitive performance which
allows monitoring of learning effects in both motor
and cognitive domains. We focus on assessing various
components of executive functions, an area that is spe-
cifically shown to be affected in PD patients [28]. This
implies that this trial will also provide novel evidence
on the impact of cognitive training on executive functionin PD which may inform future power-based studies in
this area.
This will be the first dual task training study that will
look at differences in dual task gains between freezers
versus non-freezers after stratification for these subgroups.
The results of this study will establish which training
strategy is optimal in each subgroup, taking their dif-
ferent cognitive profiles into account. Since freezers show
greater executive deficits than their non-freezing counter-
parts [31-33,75] and learn less well in dual task conditions
[34], we anticipate that freezers may benefit more from
consecutive training in order to achieve dual task learning.
In conclusion, in this DUALITY trial we will study two
different strategies aimed at improving dual tasking in
PD patients. We expect that the trial will provide novel
and clinically important information on the most effective
and safe training strategy in different patient subgroups
and in this way will contribute to developing future direc-
tions for rehabilitation targets in PD.
Consent
Written informed consent will be obtained from every
patient included in the study. A copy of the written consent
will be available for review by the Editor of this journal.
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